PhRMA urges court to stop gov­ern­ment drug price ne­go­ti­a­tions be­fore they start

In­dus­try group PhRMA yes­ter­day asked a Texas dis­trict court to halt CMS’ in­com­ing drug price ne­go­ti­a­tions be­fore they kick off in earnest next month.

The fil­ing is just the lat­est in a bar­rage of law­suits — from Mer­ck and Bris­tol My­ers Squibb to Janssen and Astel­las — tar­get­ing Pres­i­dent Biden’s sig­na­ture In­fla­tion Re­duc­tion Act, which in ad­di­tion to the new ne­go­ti­at­ing pow­er for CMS al­so in­cludes a max­i­mum out-of-pock­et cap of $2,000 start­ing in 2025 for se­niors on Medicare, and a cap on in­sulin costs at $35 per month, as well as new re­bates for drug prices that rise faster than the rate of in­fla­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER